Errors-To: <>
X-Sender: (Unverified)
Date: Wed, 04 Nov 1998 00:41:02 -0500
From: John Hammell <>
Subject: TORPEDO: The Nutraceutical Research & Education Act - NREA!!!!

IAHF List: It is imperative that we send Clint Miller to this conference to
monitor it, and I'm appealing to you all for help towards that end. If you
can help, please send a donation to Clint
Miller at 139 Northmont Dr. Statesville, NC 28625. The writing is on the
wall. If we don't torpedo the NREA, we can kiss the supplement industry
goodbye. The bill hasn't been introduced yet, but it will be, and De Felice
is VERY dangerous.

In 1990 I was one of a large number of people who had 5 minutes at the
microphone at a public meeting convened by the FDA in the aftermath of the
passage of the NLEA. FDA was mandated by law to solicit public input on how
vitamins should be reguated under the new law. People on both sides of the
issue were in attendance, and you could cut the tension in NIH's Masur
auditorium with a knife.
Ken Mehrling of Sigma Tau Pharmaceuticals was there representing De Felice,
who's product, Carnitour, they were licensed to sell. "Carnitour" is an FDA
approved pharmaceutical version of the amino acid l-carnitine. De Felice
and Mehrling want a monopoly on l-carnatine, and I heard Mehrling spout off
with all kinds of GARBAGE whereby they wanted FDA to ban l-carnatine and
ONLY allow their product to be sold.

Need I say more? Please read the following VERY carefully, and please visit
De Felice's website at to scope the jerk out. He used
to work for Pfizer, and was a fellow at NIH. I have talked with him and
he's a very charming, very greedy guy who unfortunately is also a gifted
shmoozer and he has some BIG BUCKS behind him, as symbolized by his holding
his meeting at the Waldorf Astoria in New York City, and due to his being
able to get Senators Frist, Harkin, and Congressman Pallone to attend.
Clint is going to need some $$BUCKS$$ just to get in the door----- anyone
with deep pockets who may be able to help, please call Clint at
704-924-8615. He's closer than I am, and he's the most experienced health
freedom lobbyist in the world. He deserves our help in getting to this event.

The Foundation for Innovation in Medicine (FIM)
                      10th Nutraceutical Conference

                      NUTRACEUTICALS &
                      PHARMACEUTICALS TAKEN
                      TOGETHER: A NEW HEALTH


                      A New FIM Congressional Proposal:
                      The Nutraceutical Research & Education Act
                      - NREA

                      November 10-11, 1998
                      The Waldorf-Astoria
                      New York

                      Registration Information


Nutraceuticals (include the legal-regulatory entities dietary supplements,
and medical foods) are being consumed together with pharmaceuticals by a
large percentage of the U.S. population. We must assume that to a significant
degree, nutraceuticals and pharmaceuticals interact with each other, having a
significant impact on disease- either beneficially or detrimentally. There
is little
doubt that this potentially enormous new health sector already exists.
There is
also little doubt that the medical community, health industry, and federal
government are not addressing this new explosive health sector.

FIM announces a 1 1/2 day conference which will present the current
information on the business and regulatory aspects of foods, medical foods
and dietary supplements. Also included will be presentations on actual or
virtual clinical trials of nutraceuticals and pharmaceuticals taken
together. A
medicine versus law panel regarding claims will follow each presentation. The
physicians will propose claims based on the clinical data itself. The lawyers
will propose claims based on federal law and regulations.

Products to be discussed are Benecol, Ocean Spray Cranberry Juice, St.
John's Wort, Intelligent Quisine, Zocor, Cispro, Prozac and
Antihypertensive Pharmaceuticals.


The Nutraceutical Research & Education Act - NREA

In 1991 FIM published its white paper, "The Nutraceutical Initiative: A
Proposal for Economic and Regulatory Reform". In it FIM called for
Congress to enact The Nutraceutical Research & Education Act NREA. We
believe that this proposal may be a timely solution to the current state of
confusion which would expedite the establishment of a vigorous
research-oriented nutraceutical industry.

Authorities from various health sectors will participate and make comments
and recommendations on the FIM proposal, including members of Congress,
both the House and the Senate corporate medical and legal thought leaders,
who play key roles in formulating U.S. health policy. There is little doubt
the time has come for new nutraceutical laws and regulations.

                                          NEWS ADVISORY

                      FDA announced it intends to seize cholesterol
lowering Benecol margarine
                      and ban it as a dietary supplement.


                      CONFERENCE PARTICIPANTS

                      Thomas D. Aarts
                      Executive Editor, Nutrition Business Journal

                      Nilo Cater, M.D.
                      Nutrition Scholar, Center for Human Nutrition,
University of Texas,
                      Southwestern Medical Center at Dallas

                      Lyn Ciocca
                      President, Wellness Resources

                      Stephen L. DeFelice, M.D.
                      Chairman, FIM (The Foundation for Innovation in

                      Grant W. Denison, Jr.
                      Chairman & CEO, BioMarin Pharmaceutical, Inc.

                      Senator Bill Frist, M.D. (R-Tenn)
                      Chairman, Senate Labor and Human Resources Public
Health and Safety

                      Carl Germano, RD, CNS, LDN
                      Vice President Product Development, Solgar Vitamin &

                      Samuel Gershon, M.D.
                      Professor of Psyehiatry, University of Pittsburgh

                      Peter Goldman, M.D.
                      Professor of Health Science, Department of Nutrition,
Harvard School of
                      Public Health

                      Enrique J. Guardia, Ph.D.
                      Former Vice President Technology, General Foods USA

                      Senator Tom Harkin (D-lowa)
                      Ranking Member, Senate Appropriations Labor, Health
and Human Services

                      Robert A. Hoerr, M.D., Ph.D.
                      President, Research-based Dietary Ingredient
Association (RDIA) and
                      President and CEO, GalaGen Inc.

                      Louis Lasagna, M.D.
                      Dean, Sackler School of Graduate Biomedical Sciences,
Tufts University

                      Franklin C. Lowe, M.D., MPH
                      Associate Clinical Professor of Urology, Columbia
University & Associate
                      Director, Dept. Urology, St. Luke's/Roosevelt Hospital

                      Antonio C. Martinez, II, Esq.
                      Attorney at Law, Government & Regulatory Affairs Counsel

                      Stephen H. McNamara, Esq.
                      Hyman, Phelps & McNamara, P.C. and former Associate
Chief Counsel for
                      Food, FDA

                      C. Kenneth Mehrling
                      Executive Vice President, General Manager, Sigma-Tau

                      Abbey S. Meyers
                      President, NORD (National Organization for Rare
Disorders, Inc.)

                      Representative Frank Pallone (D-NJ)
                      Member, House Commerce Subcommittee on Health and the

                      Lawrence M. Resnick, M.D.
                      Professor of Medicine & Director of Hypertension,
Wayne State University,
                      School of Medicine

                      Jur Strobos, M.D., J.D.
                      Greenberg Traurig and former Director, Policy
Research, Office of the
                      Commissioner, FDA

                      John P. Troup, Ph.D.
                      Vice President, Scientific Affairs, General Nutrition

                      Joseph M. Valenzano, Jr.
                      President, CEO & Publisher, Exceptional Parent Magazine

                      William M. Wardell, M.D., Ph.D.
                      Senior Scientific Officer & Executive Director of the
Institute for Drug
                      Research, Covance

                      Rhonda Witwer
                      Manager, Business Development, Monsanto



                      Tuesday, November 10th

                      Moderator: DeFelice

                      8:30 - 9:00 am
                      Nutraceuticals and the Congress

                      9:00 - 9:30 am
                      Nutraceutical Revolution Update: Nutraceuticals &
Pharmaceuticals Taken
                      Together: A New Health Sector; Adriamycin and
Carnitine - A Personal

                      9:30 - 10:15 am
                      Foods, Medical Foods & Dictary Supplements:
Regulatory Update on Claims

                      10:15 - 10:45 am

                      10:45 - 11:15 am
                      The U.S. Nutraceutical Market Size: Update

                      11:15 - 11:35 am
                      Research-based Dietary Ingredient Association (RDIA)

                      11:35 - 11:45 am
                      Health vs. Medical Nutraceutical Claims: What's the

                      11:45 - 12:05 pm
                      Benecol Plus Zocor and Cholesterol Lowering: An
Actual Case

                      12:05 - 12:30 pm
                      Medical-Legal Expert Panel

                      12:30 - 2:00 pm

                      2:00 - 2:20 pm
                      Prozac Plus St. John's Wort and Antidepressant
Activity: A Virtual Case

                      2:20 - 2:45 pm
                      Medical-Legal Expert Panel

                      2:45 - 3:05 pm
                      Ocean Spray Cranberry Juice plus Cispro and the
Reduction of Urinary Tract
                      Infections: A Virtual Case

                      3:05 - 3:30 pm
                      Medical-Legal Expert Panel

                      3:30 - 4:00 pm

                      4:00 - 4:20 pm
                      Intelligent Quisine plus Antihypertensive
Pharmaceuticals and Blood Pressure

                      4:20 - 4:45 pm
                      Medical-Legal Expert Panel

                      4:45 - 5:30 pm
                      Panel: Corporate Risks & Opportunities

                      5:30 - 7:00 pm


                      Wednesday, November 11th

                      Moderator: DeFelice

                      8:30 - 9:00 am
                      Sampling: Current Corporate Nutraceutical Claims

                      9:00 - 9:30 am
                      FIM Proposal: The Nutraceutical Research & Education
Act - NREA

                      9:30 - 10:15 am
                      Panel: Points of View Re: Nutraceuticals & NREA
(Germano, Guardia,
                      Lasagna, Martinez, McNamara, Mehrling, Meyer, Troup,
Valenzano, Witwer)

                      10:15 - 10:30 am

                      10:30 - 11:15 am
                      Panel Continuation with Audience Participation

                      11:15 - 12:00 pm
                      Congressional Comments (Harkin and Pallone) and

                      REGISTRATION FEE: $1,545 includes lunch and reception
                      10th. Academic rate: $895. Please make checks payable
to FIM and mail to
                      411 North Avenue East, Cranford, NJ 07016.
Registrations are also accepted
                      by phone: 908-272-2967 or fax: 908-272-4583 or here
on line by clicking on
                      this highlighted text.
International Advocates for Health Freedom
2411 Monroe St. #3 Hollywood, FL 33020 USA
800-333-2553, overseas 954-929-2905
fax 954-929-0507,,
Donations Needed For Trips to DC
To Get FDA Oversight Hearing
Due to Illegal FDA Codex Comments
& for Trips to Europe to Assist
Dr.Rath in Getting Hearing at
International Court of Justice
Against the Pharmaceutical Cartel